Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders.

Sci Rep · 2022 · PMC9474883 · PMID 36104373

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Further, the treatment group also showed a trend to a reduction in fed plasma insulin that was not statistically significant on days 14 and 21 compared to HFD control (Fig. 5 B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.